This year, an estimated 60,190 adult men in the U.S. will be diagnosed with melanoma, the 5th most common cancer among that group.
During Men's Health Month, encourage the male loved ones in your life to learn about risk factors and prevention for this type of cancer: https://lnkd.in/esdAYFU
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction, multiple sclerosis and oncology. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Tweet me: This year, an estimated 60,190 adult men in the U.S. will be diagnosed with melanoma, the 5th most common cancer in men. During #MensHealthMonth, encourage the male loved ones in your life to learn about risk factors: https://lnkd.in/esdAYFU @Alkermes
KEYWORDS: NASDAQ:ALKS, Alkermes, Men's Health Month, melanoma, Cancer